↓ Skip to main content

The Third French Alzheimer Plan: analysis of the influence of a national public health initiative on scientific research productivity and impact

Overview of attention for article published in Alzheimer's Research & Therapy, September 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)

Mentioned by

news
2 news outlets
twitter
3 tweeters

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
43 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Third French Alzheimer Plan: analysis of the influence of a national public health initiative on scientific research productivity and impact
Published in
Alzheimer's Research & Therapy, September 2015
DOI 10.1186/s13195-015-0144-z
Pubmed ID
Authors

Nicole Haeffner-Cavaillon, Patrick Devos, Sylvie Ledoux, Joël Ménard

Abstract

The Third National Alzheimer Plan (2008-2012) was a major public health initiative in France that included €200 million of funding for research in Alzheimer disease and related disorders (AD). The aim of this study was to document trends in French academic output in AD following the implementation of the plan. Academic output (i.e., number of original articles) and scientific impact (i.e., article citations) of French research in AD were obtained from the Web of Knowledge core collection database. Analyses compared the 5-year period immediately before (2004-2008) and after (2009-2013) initiation of the plan. Comparisons were made with stroke, Parkinson disease, AIDS, and diabetes in the 14 leading countries worldwide and regionally within France. Worldwide production of original scientific articles between the periods 2004-2008 and 2009-2013 increased by 39 %, and that for AD increased by 46 %. China showed the largest increase and Japan the smallest. The absolute increase in French output on AD (54.6 %) was larger than that for stroke, Parkinson disease, AIDS, or diabetes. Globally, France had the third largest relative increase in output in AD (1.7-fold), behind only India (2.5-fold) and China (1.9-fold). There was a relative 2.3-fold increase in the proportion of French AD articles in the top 1 % globally most cited, larger than that for French articles on stroke, Parkinson disease, AIDS, or diabetes. At the national level, university hospitals participated in nearly 50 % of French AD publications. Analyses by geographical area demonstrated marked heterogeneity. We observed a strong correlation between level of funding and volume of output (R (2) = 0.70), but not between funding and article impact (proportion of top 10 % globally cited articles; correlation R (2) = 0.03). Our study provides evidence of a specific positive impact of the funding provided by the Third National Alzheimer Plan in nearly doubling the global academic scientific output and increasing by 2.3-fold the top 1 % globally cited articles of France in AD research. Our bibliometric analyses provide objective and transparent information for policy makers on the relationship between research funding and academic output.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 42 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 23%
Student > Ph. D. Student 6 14%
Student > Doctoral Student 3 7%
Student > Master 3 7%
Other 2 5%
Other 6 14%
Unknown 13 30%
Readers by discipline Count As %
Social Sciences 7 16%
Medicine and Dentistry 6 14%
Agricultural and Biological Sciences 4 9%
Neuroscience 3 7%
Economics, Econometrics and Finance 2 5%
Other 6 14%
Unknown 15 35%

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 October 2020.
All research outputs
#1,386,299
of 19,157,212 outputs
Outputs from Alzheimer's Research & Therapy
#238
of 994 outputs
Outputs of similar age
#23,957
of 259,771 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#1
of 1 outputs
Altmetric has tracked 19,157,212 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 994 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.9. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 259,771 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them